Dapagliflozin for renal protection after heart transplantationHeart transplant recipients face progressive renal impairment under calcineurin inhibitor exposure. The randomized DAPARHT trial evaluates dapagliflozin to preserve kidney function, with prespecified endpoints including eGFR slope, albuminuria, and acute ki...
Read more